{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:20:16Z","timestamp":1758759616836,"version":"3.44.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.thromres.2022.02.019","type":"journal-article","created":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T18:54:53Z","timestamp":1645901693000},"page":"16-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Efficacy of parenteral formulations of desmopressin in the treatment of bleeding disorders: A systematic review"],"prefix":"10.1016","volume":"213","author":[{"given":"Shreyas","family":"Sreeraman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"McKinlay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Crowther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oksana","family":"Motalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.thromres.2022.02.019_bb0005","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1182\/blood.V90.7.2515","article-title":"Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years","volume":"90","author":"Mannucci","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2022.02.019_bb0010","series-title":"StatPearls [Internet]","article-title":"Von Willebrand disease","author":"Sabih","year":"2022"},{"issue":"10","key":"10.1016\/j.thromres.2022.02.019_bb0015","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von willebrand disease: a report of the subcommittee on von willebrand factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J. Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.thromres.2022.02.019_bb0020","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/21678707.2018.1529563","article-title":"Management of mild hemophilia a","volume":"6","author":"Franchini","year":"2018","journal-title":"Expert Opin. Orphan Drugs"},{"issue":"2","key":"10.1016\/j.thromres.2022.02.019_bb0025","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/hae.12254","article-title":"Desmopressin (DDAVP) in the management of patients with congenital bleeding disorders","volume":"20","author":"Leissinger","year":"2014","journal-title":"Haemophilia"},{"issue":"8","key":"10.1016\/j.thromres.2022.02.019_bb0030","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/ajh.20940","article-title":"The use of desmopressin as a hemostatic agent: a concise review","volume":"82","author":"Franchini","year":"2007","journal-title":"Am. J. Hematol."},{"issue":"7","key":"10.1016\/j.thromres.2022.02.019_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"issue":"4","key":"10.1016\/j.thromres.2022.02.019_bb0040","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.thromres.2022.02.019_bb0045","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.thromres.2022.02.019_bb0050","doi-asserted-by":"crossref","first-page":"80","DOI":"10.13105\/wjma.v5.i4.80","article-title":"Assessing the quality of studies in meta-analyses: advantages and limitations of the Newcastle Ottawa scale","volume":"5","author":"Luchini","year":"2017","journal-title":"World J. Meta-Anal."},{"key":"10.1016\/j.thromres.2022.02.019_bb0055","unstructured":"GA Wells B Shea D O\u2019Connell J Peterson V Welch M Losos P Tugwell . The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses."},{"issue":"11","key":"10.1016\/j.thromres.2022.02.019_bb0060","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF01727749","article-title":"The subcutaneous administration of the vasopressin analogue 1-desamino-8-D-arginine vasopressin in patients with von Willebrand\u2019s disease and hemophilia","volume":"62","author":"K\u00f6hler","year":"1984","journal-title":"Klin. Wochenschr."},{"issue":"4","key":"10.1016\/j.thromres.2022.02.019_bb0065","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1365-2516.1997.00115.x","article-title":"Variability of the factor VIII response to DDAVP in a large kindred with mild haemophilia a","volume":"3","author":"Jensen","year":"1997","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.thromres.2022.02.019_bb0070","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3324\/haematol.2017.180059","article-title":"Desmopressin in moderate hemophilia a patients: a treatment worth considering","volume":"103","author":"Loomans","year":"2018","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.thromres.2022.02.019_bb0075","doi-asserted-by":"crossref","first-page":"271","DOI":"10.5482\/HAMO-12-06-0012","article-title":"Desmopressin testing in haemophilia a patients and carriers: results of a multi centre survey","volume":"32","author":"Kn\u00f6fler","year":"2012","journal-title":"Hamostaseologie"},{"issue":"2","key":"10.1016\/j.thromres.2022.02.019_bb0080","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/s-0038-1657745","article-title":"Comparison between subcutaneous and intravenous DDAVP in mild and moderate hemophilia a","volume":"54","author":"De Sio","year":"1985","journal-title":"Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2022.02.019_bb0085","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1055\/s-0038-1646051","article-title":"Intravenous and subcutaneous administration of desmopressin (DDAVP) to hemophiliacs: pharmacokinetics and factor VIII responses","volume":"58","author":"Mannucci","year":"1987","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2022.02.019_bb0090","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1055\/s-0038-1646011","article-title":"Concentrated DDAVP: further improvement in the management of mild factor VIII deficiencies","volume":"58","author":"Ghirardini","year":"1987","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.02.019_bb0095","first-page":"167","article-title":"Subcutaneous DDAVP for patients with bleeding disorders","volume":"4","author":"Grana","year":"1990","journal-title":"Hematol. Rev."},{"issue":"1","key":"10.1016\/j.thromres.2022.02.019_bb0100","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1055\/s-0038-1661458","article-title":"Comparative study of intranasal, subcutaneous and intravenous administration of desamino-D-arginine vasopressin (DDAVP)","volume":"55","author":"K\u00f6hler","year":"1986","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2022.02.019_bb0105","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00558266","article-title":"Pharmacokinetics and haematological effects of desmopressin","volume":"35","author":"K\u00f6hler","year":"1988","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.thromres.2022.02.019_bb0110","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1055\/s-0038-1642561","article-title":"Fibrinolytic and haemostatic responses to desamino-D-arginine vasopressin (DDAVP) administered by intravenous and subcutaneous routes in healthy subjects","volume":"59","author":"MacGregor","year":"1988","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2022.02.019_bb0115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0268-9499(92)90069-T","article-title":"Fibrinolytic response after injection of desamino-d-arginine vasopressin (dDAVP) in healthy volunteers","volume":"6","author":"T\u00f6rnebohm","year":"1992","journal-title":"Fibrinolysis"},{"key":"10.1016\/j.thromres.2022.02.019_bb0120","series-title":"StatPearls [Internet]","article-title":"Desmopressin","author":"McCarty","year":"2021"},{"year":"2021","series-title":"Pharmacoeconomic report: Emicizumab (Hemlibra): indication: bleeding prevention, Hemophilia A [Internet] Ottawa (ON)","author":"Hoffman-La Roche Ltd","key":"10.1016\/j.thromres.2022.02.019_bb0125"},{"issue":"6","key":"10.1016\/j.thromres.2022.02.019_bb0130","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/rth2.12354","article-title":"Desmopressin responsiveness by age in type 1 von willebrand disease","volume":"4","author":"Goldberg","year":"2020","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2022.02.019_bb0135","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.xkme.2019.02.002","article-title":"Use of desmopressin in hyponatremia: foe and friend","volume":"1","author":"Achinger","year":"2019","journal-title":"Kidney Med."},{"issue":"5","key":"10.1016\/j.thromres.2022.02.019_bb0140","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1055\/s-0038-1650645","article-title":"Prospective multicenter study on subcutaneous concentrated desmopressin for home treatment of patients with von willebrand disease and mild or moderate hemophilia a","volume":"76","author":"Rodeghiero","year":"1996","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2022.02.019_bb0145","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/hae.12763","article-title":"Practical aspects of DDAVP use in patients with von willebrand disease undergoing invasive procedures: a european survey","volume":"22","author":"Windyga","year":"2016","journal-title":"Haemophilia"},{"issue":"8","key":"10.1016\/j.thromres.2022.02.019_bb0150","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.joms.2011.03.073","article-title":"Hemostatic management in pediatric patients with type I von willebrand disease undergoing oral surgery: case report and literature review","volume":"69","author":"Bornert","year":"2011","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"4","key":"10.1016\/j.thromres.2022.02.019_bb0155","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1160\/TH10-11-0697","article-title":"Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von willebrand disease and increased von willebrand factor clearance","volume":"105","author":"Castaman","year":"2011","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2022.02.019_bb0160","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1365-2516.2005.01132.x","article-title":"Dental procedures in adult patients with hereditary bleeding disorders: 10 years experience in three italian hemophilia centers","volume":"11","author":"Franchini","year":"2005","journal-title":"Haemophilia"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384822000639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384822000639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:47:11Z","timestamp":1758736031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384822000639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":32,"alternative-id":["S0049384822000639"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2022.02.019","relation":{},"ISSN":["0049-3848"],"issn-type":[{"type":"print","value":"0049-3848"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of parenteral formulations of desmopressin in the treatment of bleeding disorders: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2022.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}